Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review - Institut Brestois des Sciences de l’Homme et de la Société Access content directly
Journal Articles Clinical Kidney Journal Year : 2021

Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review

Abstract

Although pregnancy remains exceptional in women after heart, liver or lung transplant, obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant recipients. National and international registries have described the epidemiology of maternal, foetal and neonatal complications, and transplantation societies have published recommendations on the monitoring of these high-risk pregnancies. In this review, we summarize the existing data on maternal and foetal complications of pregnancies in women after renal transplant, especially the management of immunosuppression. We also describe the few available data on the middle- and long-term outcomes of their children who were exposed in utero to immunosuppressive drugs.
Fichier principal
Vignette du fichier
sfab049.pdf (428.62 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03355311 , version 1 (27-09-2021)

Licence

Attribution - NonCommercial

Identifiers

Cite

Hugoline Boulay, Séverine Mazaud-Guittot, Jeanne Supervielle, Jonathan Maurice M Chemouny, Virginie Dardier, et al.. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clinical Kidney Journal, 2021, 14 (8), pp.1871-1878. ⟨10.1093/ckj/sfab049⟩. ⟨hal-03355311⟩
20 View
47 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More